its low low was high 2 cents very little new out since May when the Company lost its top dog (bitch - female dog). It is working on two drugs - one being asthma - which is widely used and the same company has come back with another drug to re-engineer! Sounds promising with management problems out of mind and some good news of their hard work, this stock looks like a good buy at 3 cents.